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Awards Abstract MSC-21979-I
Kinetic Tetrazolium Microtiter Assay
Microbial contamination andthe resistance of cells to disinfectants in
potable water systems of the Space Transportation System (STS) are currently
assessed terrestrially by isolating the bacteria using membrane filtration or
tube dilution techniques. Such methods are too slow and difficult, especially
in microgravity conditions. For longer duration space travel and habitation,
as well as numerous terrestrial applications, it is important to have the
capability to self-monitor water system potability. Therefore a need exists
for a rapid, quantitative, statistically valid in vitro bacterial assay.
Several methods have been developed to assay cell growth of bacterial and
mammalian cells. Such methods, particularly the standard plate count and tube
dilution methods, are lengthy, labor intensive and the results are frequently
statistically invalid because of the standard error in comparing trial
repetitions. Plate counts often do not produce viable colonies due to the
inability of the cells to proliferate under a confined class of culture
conditions. In addition, microbial clumping can lead to underestimation of
bacterial density. Clumping can also occur in tube dilutions. Both tube and
plate methods are cumbersome and require a large number of dilutions, plates
and tubes.
The invention relates to a tetrazolium cell assay method wherein
tetrazolium reduction products are dispersed in vitro using a nonionic
detergent. The in vitro cell assay method uses tetrazolium as an indicator.
The indicator includes a nonionic detergent which solubilizes a tetrazolium
reduction product in vitro and has low toxicity for the cells. The incubation
of test cells in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-
tetrazolium bromide and octoxynol (TRITON X-IO0) permits kinetics of the cell
metabolism to be determined.
Novelty exists in a tetrazolium assay method (which is surprisingly
without substantial effect on the cell growth) which permits rapid measurement
of persistent cell growth in response to growth or cytotoxic factors. The
method couples the cellular reduction of a tetrazolium salt with an in vitro
detergent which solubilizes the formazan product, permitting direct
spectrophotometric measurement of the formazan as it is produced and the
determination of cell kinetics.
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KINETIC TETRAZOLIUM MICROTITER ASSAY
Origin of the Invention
The invention described herein was made in the
performance of work under a NASA contract and is subject
to the provisions of Section 305 of the National
Aeronautics and Space Act of 1958, Public Law 85-568 (72
Stat. 435; 42 U.S.C. 2457).
Field of the Invention
The present invention relates to a method for
conducting a cell assay using a tetrazolium compound.
More particularly the present invention relates to a
tetrazolium assay method wherein tetrazolium reduction
products are dispersed in vitro using a nonionic
detergent.
J5 Background of the Invention
Several methods have been developed to assay cell
growth of bacterial and mammalian cells, important
applications include screening antimicrobial and
anticancer agents for efficacy and detection of pathogens
20 in water treatment and biologic fluids. Among commonly
used methods are tritiated thymidine uptake as described
in Twentyman, P. R., et al., British Journal of Cancer,
50:625, 1984; dye exclusion as described in Wiesenthal,
L. M., et al., Cancer Research, 43:749, 1983; standard
25 plate count or tube dilation described by American Public
Health, 17th ed., Washington D. C.: American Public
Health Association, 1989; and turbidimetric measurement
as described in Collins, C. H., et al., Microbioloqical
Methods, Boston: Butterworth; 1989, pp. 127-140. Such
30 methods, particularly the standard plate count and tube
dilution methods, are lengthy, labor intensive and the
results are frequently statistically invalid because of
the standard error in comparing trial repetitions. Plate
counts often do not produce visible colonies due to the
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inability of the cells to proliferate under a confined
class of culture conditions. In addition, microbial
clumping can lead to underestimation of bacterial
density. Clumping can also occur in tube dilutions.
5 Both tube and plate methods are cumbersome and require a
large number of dilutions, plates and tubes.
One method known for the rapid assessment of cell
growth is tetrazolium reduction assay. Colorless
tetrazolium salts are reduced in the cell by action of
I0 the enzyme dehydrogenase to form a corresponding formazan
dye compound. Since this conversion appears to be
universal in growing cells, the amount of formazan
present is generally proportional to the number of cells
in a culture. The formazan concentration can be measured
15 in situ by well known spectrophotometric techniques.
Thus, this method can be used to enumerate the growth of
microorganisms and mammalian cells in microplate
cytotoxicity assays. Microorganism tetrazolium assay is
described in Bartlett, et al. Journal of Clinical
20 Microbiology, 3(3):327-329, 1976; Jeffrey, et al. Applied
Environmental Microbiology, 51(1):150-156, 1986;' Levitz,
et al., Journal of Infectious Diseases, 152(5):938-945,
1985; and EPA 0,322,591, published May 7, 1989.
Mammalian cell assay is described in Alley, et al.,
25 Proceedinqs of the American Association of Cancer
30
35
Research, 27:389, 1986; Carmich_el, et al., Cancer
Research, 47:936-942, 1987; and Mosmann, Journal of
Immunological Methods, 65:55-63, 1983.
Since the formazan compounds produced in the cells
are typically insoluble in water, a development step has
generally been necessary to obtain color indication.
This has usually xequired the addition of a solvent such
as dimethyl sulfoxide (DMSO) or isopropanol. However,
such solvents are detrimental to cell growth and
generally terminate the culture.
Nonionic detergents have found use in dissolving
cell membranes and in solubilizing membrane-bound
proteins. In dissolving cell membranes, the detergents
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form detergent-lipid and detergent-lipid-protein mixed
micelles. The detergents prefer to form micelles rather
than bilayers due to geometries involved. Thus, an
excess of these compounds, when added to a membrane
5 suspension, will tend to shift the equilibrium of all
amphipathic molecules in the mixture from bilayer to
mixed micelle. This concentratioD is known as the
critical micelle concentration (CMC). Each detergent has
a characteristic CMC above which it exists in aqueous
I0 solution almost entirely in the micellar form.
In the case of protein solubilization, the initial
detergent ac£ion upon the membrane does not involve
rupture, but rather, some of the proteins are "extracted"
to form protein-soap aggregates. In both instances,
15 hydrophobic elements are bound to nonpolar monomer sites
on the detergent molecule. This is further detailed in
Lichtenberg et al., Biochimica et Biophysica Acta
737:285-304, 1983 and Helenius et al., Biochimica et
Biophysica Acta 415:29-79, 1975. According to
20 Schnaitman, Journal of Bacterioloqy 108:553-563 and
108:545-552, 1971, bacterial cell walls, even fmactured
ones, were surprisingly resistant to the action of TRITON
X-100 octoxynol detergent.
Microbial contamination and resistance to
25 disinfectants in potable water systems of the space
transportation system (STS) aro currently assessed
terrestrially by isolating the bacteria using membrane
filtration or tube dilution techniques. Such methods are
too slow and difficult in microgravity conditions. For
30 longer duration space travel and habitation, it will be
important to have the capability to self-monitor water
system potability, Therefore a need exists for a rapid,
quantitative, statistically valid in vitro bacterial
assay which is conducive for space use.
35 Additional references of interest include U. S.
patents 4,728,608 to Roberts et al.; 4,235,964 to
Bochner; 2,967,132 to Sacks and Russian patents 1,564,193
and 1,063,835.
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Summary of the Invention
A tetrazolium assay method, which is surprisingly
without substantial effect on the cell growth, has been
developed to permit rapid measurement of cell growth in
5 response to growth or cytotoxic factors. The method
couples the cellular reduction of a tetrazolium salt with
an in vitro detergent which solubilizes the formazan
product. The method permits direct spectrophotometric
measurement of the formazan as it is produced and
I0 determination of cell kinetics.
In one aspect, the present invention provides a
method for conducting a non-destructive tetrazolium assay
of cell metabolism. In one step, viable test cells and a
suitable growth medium are placed in a plurality of
15 wells. Indicator reagents comprising a tetrazolium
compound reduced by cell metabolism to a formazan
product, an optional electron carrier for facilitating
the tetrazolium compound reduction and a nonionic
detergent for dispersing the formazan product are added
20 to the growth medium. The metabolism of the test cells
is substantially unaffected by the indicator reagents.
The indicator-containing cells are incubated in the
presence of the reagents for a time sufficient to induce
growth in the test cells and produce the formazan
25 product. The formazan product is_dispersed in vitro by
the nonionic detergent to produce a color change in the
test medium. The extent of the color change is
determined, and cell growth can be assessed. For kinetic
assay, the culture can be incubated further and the color
30 change determination conducted at one or more later
intervals.
As a preferred embodiment, the tetrazolium compound
comprises 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-
tetrazolium bromide, the nonionic detergent comprises
35 octoxynol and the electron carrier comprises N-
methylphenazonium methosufate. The tetrazolium compound
is preferably used in an amount of from about 20 _M to
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about 250 _M. The nonionic detergent is preferably used
in an amount of from about 1 mM to about 20 mM. The
electron carrier is preferably used in an amount of from
about i00 MM to about 400 MM.
The method can further include the steps of
initially culturing the test cell to a suitable density
and adding an effector test agent such as a growth
inhibitor or a growth stimulant prior to the incubating
step. The cell growth inhibitor can be an antimicrobial
or anticancer agent. The test agent can also be a
substrate material screened for biodegradability (i. e.
capable of sdstaining cell growth) or a chemical or waste
material screened for biocompatibility (i. e. innocuous
to cell growth).
15 Brief Description of the Fiqures
Fig. 1 shows a comparison of absorption spectra of
E. coli formazan produced and developed using an
octo×ynol surfactant TRITON X-100 in vitro (207 MM final
concentration of 3-(4,5-dimethylthiazol-2-yl)-2,5-
20 diphenyl-2H-tetrazolium bromide (MTT), 16 _ final
concentration of TRITON X-100) according to the present
method (curve a) with an absorption spectrum of a
commercially prepared MTT-formazan dissolved in DMSO
(curve b) as constructed from peak absorption data
25 reported in Plumb et al., Cancer Research, 49:4435-4440;
Kasugai et al., Japan Journal of Pharmacoloqy, 52:95-100;
and Carmichael et al. mentioned above.
Fig. 2 shows a comparison of the absorption spectrum
(curve a) of Fig. 1 compared to an absorption spectrum of
commercially prepared MTT-formazan dissolved in
isopropanol (curve c) as constructed from peak absorption
data reported in Denizot et ai., Journal of Immunoloqical
Methods, 89:271-277.
Fig. 3 shows a comparison of the absorption spectrum
(curve a) of Fig. 1 compared to an absorption spectrum of
commercially prepared MTT-formazan dissolved in TRITON X-
i00 (curve d).
30
35
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Fig 4. shows a graphical representation of a
comparison of the present method for determination of the
number of E. coli cells and the plate count method.
Detailed Description of the Invention
5 Use of a nonionic detergent solubilizer for formazan
compounds in a tetrazolium assay method permits in vitro
monitoring of a cell metabolism without substantially
damaging the cell. Thus, the cell kinetic response to
both growth and cytotoxic factors can be quickly
I0 assessed. The method of the present invention can be
used, for example, to determine bacteria sensitivity to
antibacterial agents, mammalian cell sensitivity to
anticancer agents or the efficacy of growth factors used
in the field of biotechnology. In comparison to the
15 prior art, rapid results and simple procedures make the
present invention conducive for space use.
Cells monitored by the present method are preferably
cultured in a suitable aqueous nutrient medium. The
nutrient medium contains components necessary for
20 sustaining cell growth. Such nutrient media or broths
are known in the art. Examples include Mueller-Hinton
broth as recommended by the National Committee for
Clinical Lab Standards, trypticase soy broth, and the
like. The growth medium typically comprises dextrose and
25 other sugars to promote rapid growth or replication of
the cell species.
Cells useful in the present method include
microorganisms such as bacteria, fungi, protozoa and
helminths and mammalian cells taken, for example, from
30 tissue biopsies, donor animals, and the like. Depending
on the application, the cells can be obtained from a
variety of locations. The American Type Culture
Collection (ATCC) is a source for standard commercially
available strains useful, for example, in screening the
35 efficacy of a drug or antiseptic. Mammalian cells are
also cultured commercially as ATCC standard stocks. The
microorganism cells can be isolated and cultured from
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streams in water treatment processes where the cells are
present as contaminants, or from biological fluids such
as urine, stool suspensions, blood, spinal fluid, tissue
suspensions, and the like where the cells are present as
5 pathogens.
The indicator component in the present method is a
tetrazolium compound which Rermits chromogenic
determinations of cell metabolism. Suitable tetrazolium
compounds are relatively colorless in an unreduced state,
10 but are reduced to a formazan dye in a reduced state.
Such compounds are particularly useful because the
formazan is Made by a cell at a consistent uniform rate.
While it has been found that further reduction reactions
involving the formazan compounds can result in other
15 products which are colorless, these reactions are
generally not significant during the time frame of the
present method.
Since certain tetrazolium compounds can potentially
be toxic to some types of microorganisms at a given
20 concentration, suitable tetrazolium compounds should be
substantially innocuous at a concentration useful for
producing a visually detectable color change.
Examples of suitable tetrazolium compounds include
2,3,5-triphenyl-2H-tetrazolium chloride (TTC)
25 commercially available under the trade designation RED
TETRAZOLIUM, 2,5-diphenyl-3-(_-aaphthyl)-l-tetrazolium
chloride commercially available under the trade
designation TETRAZOLIUM VIOLET (TV), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide
30 (MTT), 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyl
tetrazolium chloride (INT), 3,3'-(4,4'-
biphenylene)bis(2,5-diphenyl-2H-tetrazolium chloride
commercially available under the trade designation
NEOTETRAZOLIUM, 3,3,-(3,3'-dimethoxy-4,4'-
35 biphenylene)bis(2,5-diphenyl-2H-tetrazolium chloride
commercially available under the trade designation BLUE
TETRAZOLIUM, 3,3'-(3,3'-dimethoxy-4,4'-biphenylene)bis(2-
(4-nitrophenyl)-5-diphenyl-2H-tetrazolium chloride)
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commercially available under the trade designation
NITROBLUE TETRAZOLIUM, 3,3'-(3,3'-dimethoxy-4,4'-
biphenylene)bis(2,5-bis(4-nitrophenyl)-2H-tetrazolium
chloride) commercially available under the trade
5 designation TETRANITROBLUE TETRAZOLIUM, and the like.
Other tetrazolium compounds can also be obtained from
various suppliers, such as, for example, Sigma Chemical
of St. Louis, MO or Polysciences of Warrington, PA. The
most preferred tetrazolium compound is MTT. MTT has been
10 found to have a minimal toxic effect on cell growth and
also obtains a distinct purple color upon reduction to
the formazan'constituents.
The tetrazolium compound is typically used in the
present method in an amount of at least about 1 MM and
15 preferably in an amount from about 20 _M to about 250 _M.
The color developing component of the present method
is a mild nonionic detergent or surfactant. Such
detergents have been found to solubilize and/or
homogeneously disperse hydrophobic formazan compounds
20 which are ordinarily insoluble in the aqueous test
medium. Furthermore, such detergents are subs_tantially
innocuous to most cell types at low concentrations and
can therefore be used in vitro (at appropriate
concentrations) without substantially adversely affecting
25 the growth in the culture. Thus, the color change can be
followed in a fashion which is _ neither substantially
interfering nor destructive to the cell culture.
Choice of detergent depends on formazan solubilizing
sensitivity and degree of toxicity to a given cell type.
30 It is known that microorganism cells are more resistant
to a detergent than mammalian cells and that injured
cells are more sensitive to a detergent than uninjured
cells. In general, however, it has been found that cell
disruption can be substantially avoided in the present
35 method while maintaining required formazan sensitivity.
This is due in part at least to the high sensitivity of
the detergent to the formazan product. It is believed
that competing hydrophobic formazan molecules in the test
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medium are preferentially bound to the nonpolar monomer
sites in the detergent molecule.
Overall, variables important in detergent selection
include speed at which the formazan-detergent aggregates
5 are formed, critical micelle concentration, intensity of
the developed color, influence on cells with membrane
injury and sensitivity of the formazan absorption
spectrum to changes in cell number, nominal variations in
pH and variations in volume of the growth medium.
10 Examples of classes of nonionic detergents are
alkylene oxide ethers of phenols, fatty acids and alkyl
mercaptans ; "alkylene oxide esters of fatty acids,
alkylene oxide ethers of fatty acid amides ; the
condensation product of alkylene oxide with partial fatty
15 acid esters, and the like wherein the polyoxyalkylene
chain can contain from 4 to about 30 alkylene repeat
units and the alkylene unit has 2 or 3 carbon atoms.
A preferred class of nonionic detergents includes
polyethylene oxide ethers of para C8 or C_ alkylphenol
20 exemplified by octoxynol and nonoxynol. Octoxynol has
the formula:
2-A
(CH 3 ) 3CCH2- C _ O (CH2CH20) H
CH 3
wherein n is the number of ethylene oxide repeat units
and can vary from about 5 to about 15. Also known as
25 polyethylene glycol p-isooctylphenyl ether and
octylphenoxy polyethoxyethanol, octoxynol where n is 9 to
I0 is commercially available under the trade designations
CONCO NIX-100, IGEPAL CA-630, NEUTRONYX 605 and TRITON X-
I00. TRITON X-'I00 is a tradename of Rohm & Haas.
30 Octoxynol (N.F. i is a mixture wherein n ranges from 5 to
15 with an average of i0. Octoxynol-9 has an average
composition of n=9.
Nonoxynol has the formula:
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CgHIg_O(CH_CH20) nH
10
15
2O
25
30
35
wherein n is the number of ethylene oxide repeat units
and can vary from about 4 to about 30. Nonoxynol is
commercially available under the tradenames CONCO NI,
DOWFAX 9N, IGEPAL CO, MAKON, NEUTRONYX 600'S, NONIPOL NO,
POLYTERGENT B, RENEX 600'S, SOLAR NP, STEROX, SURFONIC N,
T-DET-N, TERGITOL NP and TRITON N.
Specific representative examples of other suitable
nonionic detergents include n-dodecyl-_-D-maltoside (DM),
n-dodecyl-_-D-gluco-pyranoside (DP), diethyleneglycol
monopentyl ether (DE), polyethoxyethanol lauryl ether,
polyoxyethanol sorbitan monolaurate commercially
available under the trade designation TWEEN-20,
polyethylene glycol fatty alcohol ether commercially
available under the trade designation TERGITOL-15-S-30,
polyoxyethanol sorbitan monooleate commercially available
under the trade designation TWEEN-80 and polyethylene
glycol monododecyl ether commercially available under the
trade designation LUBROL PX and nonionic detergents
commercially available as NP-35 and NONIDET-P40. In the
present method, octoxynol/TRITON X-lO0 is a most
preferred detergent.
The detergent is generally used in an amount of from
about 0.5 mM to about 400 mM, preferably from about 1 mM
to about 20 mM.
An electron carrier is an optional but preferred
component of the present method to facilitate tetrazolium
salt reduction by the cells. The electron carrier
transports electrons used in the redox reaction and can
enhance the speed and colo_ intensity of the color
change. Examples of suitable electron carrier compounds
include N-methylphenazonium methosufate (PMS)
commercially available from Polysciences, N-
ethylphenazonium ethosulfate commercially available from
ICN Biochemicals of Plainview, NY and phenazine N-oxide
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also commercially available from ICN Biochemicals. A
preferred electron carrier is PMS.
The electron carrier is typically used in an amount
of from 0 to about 600 _M and preferably used in an
amount of from about i00 _M to about 400 FM.
The present method preferably comprises an in vitro
indicator composed of MTT, octoxynol (TRITON X-100) and
PMS. This indicator was found to have a relatively high
sensitivity and compatibility for both microorganism and
mammalian cells.
In many applications, the method will include an
addition of 'an effector agent such as antimicrobial
(including both chemotherapeutic and antiseptic),
antibiotic, anticancer agents and combinations thereof
for efficacy assessment. Other agents can include growth
factors and chemical materials and waste streams for
environmental toxicity testing. In addition, a substrate
material can be added to test for biodegradability.
Specific representative examples of antiseptic
antimicrobial agents include iodine, hydrogen peroxide,
chlorine, benzalkonium chloride, hexachlorophene,_ and the
like. Specific representative examples of
chemotherapeutic antimicrobial agents include isoniazid;
ethambutol; sulfonamides such as sulfamethoxazone, para-
aminobenzoic acid, sulfanilamide, and the like;
nitrofurans such as nitrofurantoin, nitrofurazone,
nifuroxine, and the like; trimethoprim; and nalidixic
acid. Specific representative examples of antibiotics
include natural penicillin; semisynthetic penicillins
such as ampicillin, methicillin, oxacillin, and the like;
aminoglycosides such as streptomycin, neomycin,
gentamicin; ceRhalosporins such as cephalothin,
cefamandole, cefotaxime and moxalactam, and the like;
tetracyclines; chloramphenicol; macrolides such as
erythromycin; polypeptides such as bacitracin;
vancomycin; rifamycins such as rifapin; and the like.
Specific representative examples of antifungal agents
include polyenes such as nystatin, amphotericin B, and
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the like; imidazoles such as ketoconazole, miconazole,
and the like; and griseofulvin. Specific representative
examples of antiprotazoan and antihelminthic agents
include, quinine, chloroquine, emetine, metronidazole,
5 niclosamide, piperazine, and antimony compounds.
The effector agent will typically be used in an
amount which varies based on the number of cells in the
test and an estimated power of the agent involved.
Since the metabolism of both microorganism and
10 mammalian cells can now be monitored in vitro without
substantially impairing cell activity, the present method
has use in any biologic application wherein an extent of
cell proliferation in various environments is important
knowledge: The number of cells present in a pure culture
15 can be accurately estimated from the time required for
the appearance of color. This is based on the fact that
cells of the same variety produce similar amounts of
dehydrogenase.
Agents which either inhibit or stimulate cell growth
20 (i. e. effector agents) can be rapidly screened. The
effectiveness of antimicrobial disinfectants, antibiotics
and anticancer agents can be determined. In addition,
microorganism resistance to such agents can be detected
as well as genetic alterations in Ames test
25 microorganisms. As another related application, the
environmental toxicity of chemic_l substances or waste
products can be gauged (i. e. the degree to which the
product adversely affects cell metabolism).
Agents which enhance cell growth have numerous
30 applications in environmental, agricultural and
biotechnology fields. Bacterial species containing genes
inserted by recombinant DNA techniques are cultured in
bioreactors wherein expression of the artificial gene
produces a desired product. Cultured yeasts and other
35 microbes have a variety of food producing and waste
disposing applications.
As a further application, the present method can be
used in screening materials for biodegradability (i. e.
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the degree to which the material (as substrate) sustains
microorganism cell growth).
The present method is conveniently carried out in a
conventional 96 well microtiter plate wherein the well
generally has a volumetric capacity of 250 _L. Multiple
repetitions are preferably used so that the results can
be evaluated statistically as well as quantitatively.
Each microplate permits 96 assays to be conducted
simultaneously. It is recognized that culture plates
having a greater or fewer number or wells could also be
used.
Typically a source of cells is obtained either from
a stock culture grown on a medium such as agar using
conventional techniques or from a sample of bodily fluid
to be tested. If the cells are grown in a stock culture,
they can be swabbed into suitable nutrient broth or
sterile reagent grade water for preparing cell dilutions
having an appropriate concentration. Solutions of MTT,
TRITON X-100, and PMS having an appropriate concentration
can also be prepared by diluting stock solutions of the
reagents. Each assay generally comprises from nbout 105
to about 108 cells.
The microtiter plates are then prepared (in
triplicate or however many replications are desired) by
adding to each well a sufficient amount of nutrient
broth, cell suspension, antimicr_bial/effector agent to
be tested, if appropriate, and the indicator solutions.
The plate is shaken for a short period of time (30
seconds is typically adequate) and then placed in an
incubating environment at a suitable temperature for a
sufficient amount of time to obtain a color indication.
Color change over time can be evaluated using a
spectrophotometric analyzer combined with an incubator to
obtain kinetic plate readings. An Thermo_x microplate
reader commercially available from Molecular Devices
Corp. of Menlo Park, Ca. is a suitable device.
While the exact test duration (incubation time) will
vary based upon the concentration of the indicator
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reagents used and the type and quantity of cells per
well, the test duration will typically be 20 to 120
minutes and is subject to practitioner preference.
The present method is further illustrated by the
following examples:
Examples
Microorqanisms
Escherichia coli and Citrobacter freundi bacteria
were isolated from the tap water distribution system of
10 the City of' Houston, Tx. and provided by the Water
Quality Control Div.
Bacillus lichenformans were isolated from the space
shuttle (STS 48) potable water system.
Two Pseudomonas cepacia strains used were isolated
15 from the space shuttle potable water system of STS 39 and
STS 48 and another was commercially obtained (ATCC
49129).
Candida albicans (ATCC 14053) were commercially
obtained.
20 The microorganisms were maintained on standard
methods agar (SMA) unless otherwise noted. C. albicans
was maintained on sabouraud dextrose agar (SAB). Agar
media were obtained from BBL Microbiological Systems of
Cockeysville, Md.
25 For each assay, the microorganisms were freshly
cultured on the agar plates at 30°C. Two or three hours
prior to the assay incubation temperature was raised to
35°C. Test microorganisms were swabbed off the agar
surface and suspended in sterile reagent grade water
30 (Milli Q water system) obtained from Millipore Corp. of
Bedford, Ma, to a turbidity of 0D59_=I.0. This density
was found equivalent to 2x109 E. coli, B. lichenformans,
and P. cepacia using the spread plate technique given in
American Public Health 17th ed. From this value, cell
35 amounts for dilutions were extrapolated.
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Mammalian Cells
Mammalian cells comprised CESS human lymphoblastic
cells, (ATCC TIB 190).
The mammalian cells were maintained in RPMI-1640
5 comprising 25 mM Hepes buffer and L-glutamine obtained
from Whittaker Bioproducts. The RPMI-1640 was
supplemented with I0 wt % fetal bovine serum (FBS)
obtained from Gibco Laboratories of Grand Island, NY and
40 _g/ml of gentamicin obtained from Sigma Chemicals.
I0 The cells were incubated for 24 hours at 37°C in 5 vol %
CO 2. Viable cell number was determined before each
experiment by a trypan dye exclusion technique (trypan
blue 0.4%) using a hemocytometer.
All trials used cultures in the exponential growth
J5 phase.
2O
25
3O
Reagents
Reagents used in the examples including the
tetrazolium compounds, detergents, PMS, dyes, antibiotics
and antiseptics were typically obtained from Sigma
Chemical unless otherwise noted.
Tetrazolium Assay Procedure
For microorganisms, the tetrazolium assay was run in
triplicate using 96 well microtiter plates. Cell
dilutions having a turbidity reading of ODsQ0_=0.6 were
prepared from the more concentrated stock suspension.
Typically, an aliquot of 25 _L of the diluted cell
suspension was added to each well followed by a 50ML
aliquot of doublw strength trypticase soy broth. Next,
the following aliquots were added to the wells: 15 _L of
1.2 mM MTT; i0 ML of 0.06 mM PMS; and 25 _L of 160 mM
TRITON X-100. The plate was mixed for 30 seconds on a
Hyperion plate shaker from Fisher Scientific and placed
into the Thermomx microplate reader for incubation and
analysis of the formazan production. The plates were
MSC-21979-I
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incubated at 30°C. The formazan production was followed
spectrophotometrically over time using a test wavelength
of 590 nm and a reference wavelength of 650 nm. A
background control comprising an identical plate minus
5 the cells was also run to account for spontaneous changes
in the optical density.
Assay of mammalian cells was ,similar to that of
microorganism cells except that 150 _L of mammalian cell
dilution (5x105 cells) in RPMI 1640 was used and the
I0 incubation temperature was 37°C.
For each assay test, negative controls were
conducted to determine whether tetrazolium reduction was
caused by factors other than cell metabolism during the
test run. Controls were conducted for the presence of
15 residual dehydrogenase enzyme from the stock culture and
for the influence of other reagents on tetrazolium
reduction.
The control for residual enzyme was run by
conducting the tetrazolium assay (as described above) on
20 freshly killed cells. The cells were killed using
iodine. The amount of iodine required was detelmined by
the plate count method. The control for the influence of
other reagents on tetrazolium reduction was run by
conducting assays containing only the tetrazolium
25 compound and the reagent to be tested. The controls
indicated that outside influence on the final
spectrophotometric determination for formazan was less
than about 2.5 %.
MSC-21979-I
Express Mai] Certificate No. B80802187
Patent AppTication
17
Examples i and 2
Cell Concentration vs. Formazan Production for E. Coli
and CESS
Tetrazolium assays according to the above procedures
5 were performed on E. coli (Example I) and CESS cells
(Example 2) wherein cell amounts on microtiter plates
varied between 105 and 107 cells/well. The formazan
production was followed over time. The final
concentration of TRITON X-100 was 16 mM. The E. coli
I0 assay time was 45 min and the CESS assay time was 2 hr.
Results" are given in Table i. Graphical
representations of the data show that formazan production
as determined by spectrophotometric analysis was linearly
proportional to cell numbers with an r2=0.99 for E. coli
15 and r2=0.98 for CESS. The data also suggest that 107
cells/well give an optimal assay time of from 30-45
minutes for microorganism cells. As a control, plates
containing 107 cells/well were incubated at room
temperature to show that carry over metabolism (from the
20 stock culture) was not responsible for the formazan
production observed (but rather production was due to
growth under the prescribed conditions).
Table 1
ExampLe1
(E. call)
Cone. Ce((s
per Welt
(xlO 6)
Absorbance"
(00 a 590-6590
rim)
0.33
41.3
ExampLe2 (CESS)
1./.4
Conc. Ce((s
per Well
(xlO 5)
10.510.5
20,9 0.68 20.9 0.66
31.3 1.04 31.3 1.03
1.4341.8
Absorbance
(00 -_ 590-6590
rim)
0.34
*-Each data point represents the average of 8 welts plus or minus
25 the standard'deviation.
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Example 3 and Comparative Examples 1-3
Comparison of in vitro TRITON X-100 with Post-incubation
Solvents and TRITON X-100
In the following example and comparative examples,
formazan solubilizing capacity of in vitro TRITON X-100
of the present invention was compared to DMSO and
isopropanol solvents and TRITON X-100 added post
incubation.
Tetrazolium assays of E. coli were conducted as
described above, except that in the comparative examples,
TRITON X-100 detergent was either omitted or added at the
end of the incubation period. Capacity was based on
color intensity determined by spectrophotometric
absorbance at 590-650 nm. The assay time was 30 min, the
final concentration of TRITON X-100 was 16 mM and the
amount of DMSO or isopropanol added was 120 _L.
Results shown in Table 2 indicate the superior
developing efficiency of TRITON X-100 especially when
added in vitro as compared to DMSO and isopropanol.
3
Camp. I
Comp.2
Comm. 3
Table 2
Oeve[oper
TRITON X-tO0
(in vitro)
Absorbance
(O.D. (590-650 rim))
0.77
TRITON X-IO0 0.66
(post- incubation)
DMSO 0.23
isopropanct 0,17
Examples 4-36
Comparison of Nonionic Deterqents for In vitro Formazan
Solubilizinq
Tetrazolium assays of El coli cells were conducted
in vitro as described above except that the tetrazolium
compound, detergent type and detergent concentration were
varied. Results are given in Table 3. (One weight
percent is approximately 16 mM final concentration.)
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Exampte
NO,
4
Detergent
DP
Table 3
DE
1.0
Tetrazo! ium
cm_
MTT a
Absorbance e
1.0
<0.1
5 DP 0.1 MTT <0.1
6 DM 1.0 MTT 0.88
7 DM 0.1 MTT 0.13
8
TRITON X-lO0
.TT
MTT
<0. I
9 DE 0.1 <0.1
10 TRITON X-t00 1.0 MTT 1.11
11 MTT 0.650.1
|NTb12 DP 1.0 0.28
13 DP 0.1 IWT 0.23
14 DM 1.0 IRT 0.43
15 DM 0.1 INT 0.39
16 DE 1.0 INT 0.11
17 DE 0.1 INT 0.25
18 TRITON X-IO0 1.0 ]NT 0.61
19 TRITON X-lO0 0.1 IWT 0.42
20 DP 1.0 TTCc <0.10
21 DP 0.1 TTC <0.10
TTCDM22 1.0 0.15
23 DM 0.1 TTC 0.10
2.4 DE 1.0 TTC <0.10
25 DE 0.1 TTC <0.10
26 TRITON X-tOO 1.0 TTC 0.35
27 tAztON x-loo o.1 ttc 0.2S
28 DP 1.0 TVd 0.15
29 DP 0.1 IV <0.10
30 DN 1.0 TV 0.32
0.1 tv 0.15
1.0 TV <0.10
0.1 TV <0.10
31 DM
32 DE
33
34
DE
TRITON X-lO0 TV
TVTRITON X-t0035
1.0
0.1
0.72
0.61
a-Absorbancemeasuredat 5P0-6$Onmafter 2 hr.
b-Absorbance measured at 450-650 nm after 2 hr.
c-Absorbance measured at 450-650 nm after 24 hr.
d-Absor_e measured at $90-650 m after 24 hr.
e-Absorbance reading represents an average of 3 wells plus or minus the
standard deviation.
Although the detergents tested had a similar
critical micelle' concentration and molecular weight,
various degrees of formazan dispersion were observed.
TRITON X-100 was the most effective detergent and TRITON
X-100/MTT was the most effective indicator combination.
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Examples 36 and 37
Formazan Metabolization versus Incubation Time
In the following examples, tetrazolium assays of E.
coli cells were conducted in vitro as described above for
microorganisms except that the final TRITON X-100
concentration was reduced from 16 mM (Example 36) to 1.6
mM (Example 37) and the spectrophotometric evaluation was
continued for 210 min. The number of cells per well was
about 2.5 x 107 . Results are given in Table 4.
Time (min)
Table 4
A_or_nce*
(O.D. _ 590-650 rm)
Example 36 Exmpte 37
l,
20 0.36 0.32
40 0.63 0.6
100 1.58 1.3
130 I.&2 0.77
210 1.65 0.36
*-Each a_orMxe repres_ts an average of 8 wefts pt_ or minus the sta_ard
_viat i_.
Data in Table 4 show that formazan was 'further
reduced by cell metabolism over time to a colorless
15 product. This was demonstrated by lowering TRITON X-100
concentration from 16 mM (I wt %) to 1.6 mM (0.i wt %).
A possible explanation for this result is that in the
higher concentration run, a sufficient amount of monomer
sites which bind formazan were present and in the low
20 concentration run, the formazan was only partially bound
allowing further reduction to the colorless state.
25
Example 38 and Comparative Examples 4 and 5
Comparison of the Absorbance Spectra of MTT-Formazan in
TRITON X-IO0 to MTT-Formazan in Other Solvents
For the following examples and Comparative examples,
a tetrazolium assay of E. coli cells was conducted in
vitro as described above with a final TRITON X-100
concentration of 16 mM and a final MTT concentration of
MSC-21979-1
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207 _M. The spectrograph from this assay was obtained
(spectrum (a) in Figs. 1-3). This spectrograph was
overlaid with spectrographs constructed from peak
absorption data obtained from the references Plumb et
al., Kasugai et al., Carmichael et al., and Denizot et
al. for a commercially produced MTT-formazan (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-2B-formazan (from Sigma
Chemical) (207 _M)) dissolved in DMSO, (spectrum (b) in
Fig. i, Comparative Example 4); isopropanol (spectrum (c)
in Fig. 2, Comparative Example 5); and TRITON X-100
(spectrum (d) in Fig. 3, Example 38).
The absorbance peaks of the MTT-formazan in DMSO
(Fig. l(b)), isopropanol (Fig. 2(c)), and TRITON X-100
(Fig. 3(d)) were very different. However, the commercial
formazan dispersed in the TRITON X-100 (Fig. 3(d)) had an
identical absorbance peak as the MTT-formazan produced by
E. coli and dispersed in vitro with TRITON X-100 (Fig.
3(a)). This is evidence that use of TRITON X-100 gives a
stable absorption spectrum which is relatively unaltered
by assay conditions.
Example 39 and Comparative Example 6
Sensitivity of E. coli to Iodine Inhibition
An E. coli strain (City of Houston) was contacted
with iodine and then assayed _" using the present
25 tetrazolium method to determine the susceptibility of
these bacteria to iodine inhibition. Fresh iodine stock
solutions were prepared in reagent grade water by the
N,N-diethyl-p-phenylenediamine colorimetric method
described in American Public Health 17th ed. using a DR/2
30 spectrophotometer, commercially available from Hach Co, of
Loveland, Co. so that a final concentration of each
solution was between 2-20 ppm iodine. E coli cells
maintained as described earlier were resuspended in
sterile reagent grade water to a concentration of
35 0D590_=0.6 then diluted again 1 part cells to 2 parts
water. Aliquots (50 ML) of both the iodine stock
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solution and cell suspension were placed in the wells for
a contact time period of i0 min at 25°C. At the end of
this time, the iodine was neutralized with i0 ML of
0.02mM of sodium thiosulfate. The amount of sodium
5 thiosulfate required for neutralization was determined
from a dose response curve showing the minimum
concentration needed to neutralize 40 ppm iodine. The
plate was mixed for 30 seconds after which 50#L of the
soy broth was added followed by 15 _L of 1.2 mM MTT, i0
I0 _L of 0.06 mM PMS and 25 _L of 160 mM of TRITON X-100.
The plates were again shaken for 30 seconds and incubated
at 30°C. The effect of the iodine on inhibiting cell
growth was determined by comparing the reduction in
absorbance of the dosed cells against a control
15 population not dosed with iodine. The results are given
in Table 6.
The iodine sensitivity of the same E. coli cells was
also determined by a plate count assay. A comparison of
the data represented in Fig. 4. Both method showed that
20 the number of cells was reduced linearly with increasing
iodine concentration. There was also no significant
difference in the curve slopes for each method (p=0.84,
n=6) establishing the present tetrazolium method as a
valid method for enumerating relative numbers of viable
25 cells following iodine exposure.
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COG.
(ppm)
0
I
2
3
4
5
6
7
8
lO
Table 6
Inhibition (%)
Ex. 39
E co(i
13.1
Ex. 40
P. cepacia
(ATCC
49129)
0
6.7
Ex. 41
P. cepacia
(STS 39)
Ex. 42
P. cepacie
($TS 48)
8.6
37.4 14.3 10.0
73.7 37.6 6,2 20.1
96 54.8 11.2 24.2
100 72.6 17.5 44.5
100 27.5 48.8
42.5 68.9
56.2 81.8
71.7 100
100
Examples 40-42
Iodine Inhibition of Space Shuttle Isolates
In the following examples, the effect of iodine
5 disinfectant on bacteria isolates (P. cepacia) taken from
the potable water system from two space missions was
determined by the tetrazolium assay method described in
Example 39 and Comparative Example 6. In addition,
commercially obtained P. cepacia (ATCC 49129) were run as
10 a control to determine the acquired resistance of the
space shuttle strains to iodine. ..Results are given in
Table 6. It can be seen that the strains taken from the
space shuttle had acquired a significant resistance
requiring an iodine concentration as much as a 67 %
15 greater for the strain from STS 39 (Example 41) compared
to the stock strain (Example 40).
2O
Examples 43-46
Benzalkonium Chloride Inhibition
In the following examples, the present tetrazolium
assay method was used to determine the percent viability
MSC-21979-1 Express Mail Certificate No. B80802187
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of several bacteria strains in the presence of
benzalkonium chloride (BAC). Data are given in Table 7.
8enzai konium
Chloride
(ppm)
Table 7
8acteria viability (%)
B.
lichenformans
(STS 48)
E. coti
(City of
Houston)
Ci trobacter
f reundi
(City of
HoUston)
100
Candida
abicans
(ATCC 14053)
0 100 100 10o
2 91.6 89.1 88,6
3 66.6 47.8 32.8 50.5
4 38 14.1 15,7
S 0 0 0 0
Example 47-53
Reduction of Benzalkonium Chloride Inhibition of E. coli
in the Presence of Various Metal Cations
In the following examples, E. coli cells were
contacted with 3 ppm of benzalkonium chloride (BAC) and
varying concentrations of a variety of metal cations and
I0 then assayed using the present tetrazolium method to
determine the reduction of antibiotic properties_(if any)
of BAC in the presence of the cations.
For the various cations, 200 mM stock solutions of
AICI 3, SrCl2, BaCI2, CaClz, MgCI2, KCI and NaCI metal
15 chlorides were initially prepared. These solutions were
then diluted to a concentration on the order of 0.4 mM.
Aliquots of the cation stock solution were added to the
wells containing E. coli cells (50 ML, ODsw_=0.6) and BAC
to give the desired cation concentration and the
20 microplates were shaken for 30 sec. The soy broth and
tetrazolium assay solutions were added to the wells as
described previously and the microplate was shaken again
for 30 sec. The cell metabolism was followed using
spectrophotometric anaylsis. The percent reduction in
25 inhibitory activity of BAC caused by the cations was
determined by comparison to control wells containing BAC
but no cations. Results are given in Table 8.
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Table 8
Example Cation
Type
47 At +3
48 Sr +2
49 Ba +2
50 Ca +2
51 M_ +2''
52 K +
53 _a +
,Inh!bition (%1 non-normalized)
Cation ¢oncent rat i on(/IM)
0 0.0003 0.0005 0.0008 0.0010 0.0025 0.0050 0.0075 0.0100
i
64.2 42.6 34.? 18.3 14.8 9.9 10.4 12.2 2.3
59.4 43.8 23.3 15.7 14.9 3.9 8.3 13.6 9.2
56.8 53.2 51.9 45.2 36.7 22.4 14.0 3.8 6.8
49.3 47.? 44.9 38.5 38.2 28,4 14.1 8.2 11.0
59.2 52.5 52.9 46.2 45.5 38.0 34.4 25.4 13.0
58.9 55.5 57.3 57'.3 53.3 60.4 55.1 64.6 48.9
59.7 57.6 56.3 54.6 47.4 55.8 60.4 58.9 45.7
It can be seen from the data that increasing
concentrations of cations reduced the effectiveness of
BAC inhibition activity. However, the affect of
increasing K ÷ and Na ÷ cation concentration was much less
pronounced indicating that the cation valence was an
important factor.
Examples 54 and 55
Effect of TRITON X-100 on Injured E. Coli
]0 In the following examples, the effect of TRITON X-
I00 concentration on E. coli cells damaged by iodine
exposure was examined. Using the procedures outlined in
Example 39 and Comparative Example 6, wells were
established containing iodine injured and non-injured E.
15 coli cells. To some of the injured cells, tetrazolium
assay reagents were added wherein the TRITON X=I00
strength was either 16 mM (i wt %) or 1.6 mM (0.i wt %).
In addition, reference wells containing only normal (non-
injured cells) were set up as well as control wells
20 containing injured cells without tetrazolium reagents and
normal cells with tetrazolium reagents (both 1.0 and 0.I
wt % TRITON X-100). The wells were then incubated for 40
min at 30°C as for a normal tetrazolium assay. Following
the incubation period, viable cells were enumerated using
25 the plate count method by swabbing from the wells to m-T7
agar. The level of injury was reported as the percent
difference in the plate counts between the reference or
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control wells without TRITON X-100.
given in Table 9.
The results are
ExampLe TRITON X-t00
(wt %, finat)
Table 9
Difference in plate count based on reference or contro[ pl.ate
(5{)
Concentration Iodine (PPM)
2
i
3
26.2
4
1.6Ref.IControt 0 100 74.3
54 0.1 96.2 76.5 20.2 1.6
Ref./Control 0 100 89.7 56.6 13.4
55 1.0 94.2 57.1 30.7 18.8
It can be seen that the TRITON X-100 at 1.0 wt % had
5 a large negative effect on the viability of iodine
damaged cells compared to the control. However, at the
lower concentration, the TRITON X-100 detergent had
little negative effect on the cells.
The foregoing description of the biotechnical assay
I0 method is illustrative and explanatory thereof. Various
changes in the reagents, apparatus, and particular
techniques employed will occur to those skilled in the
art. It is intended that all such variations within the
scope and spirit of the appended claims be embraced
15 thereby.
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Abstract of the Invention
A method for conducting an in vitro cell assay using
a tetrazolium indicator is disclosed. The indicator
includes a nonionic detergent which solubilizes a
5 tetrazolium reduction product in vitro and has low
toxicity for the cells. The incubation of test cells in
the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide and octoxynol (TRITON X-
I00) permits kinetics of the cell metabolism to be
I0 determined.
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